ANIEMEA-P-GB-202600242 | February 2026
Authors:
Nick Makwana, MD
Publish Date:
December 2021 | 53 min
Abstract:
In this course, you’ll learn how multi-ethnic communities have less consistent access to specialist NHS care and understand why there are poor clinical outcomes in the UK BAME population in relation to allergic conditions.
Once you have watched this video, please remember to complete your self-reflective notes to contribute towards your continuing professional development. You will then be able to access your Certificate of Completion.
LEARNING OBJECTIVES
Discuss the evidence demonstrating a higher incidence of anaphylaxis and food allergies in the UK BAME population compared to Caucasian population groups.
Highlight the barriers that are faced accessing healthcare by BAME communities and how this may impact on long term health outcomes in relation to allergic disease.
Discuss what measures need to be implemented to improve health outcomes in allergy for multi-ethnic communities.
AUTHOR(S) BIO
NICK MAKWANA, MD
Consultant Paediatrician (Paediatric Allergy), Department of Child Health, Sandwell and West Birmingham NHS Trust
Group Director (Women & Child Health), Sandwell and West Birmingham NHS Trust
MBChB Paediatric Curriculum Lead and Senior Clinical Lecturer, University of Birmingham
Dr Makwana graduated from the University of Birmingham Medical School and completed his paediatric training within the West Midlands. His interest in allergy started whilst he was a registrar at Birmingham Heartlands Hospital. He went on to work at Alder Hey Hospital in Liverpool and gained an MD from the Department of Clinical Infection, Microbiology, and Immunology at the University of Liverpool. He is currently a consultant at Sandwell and West Birmingham NHS Trust and leads the multi-disciplinary paediatric allergy service cross site. The multi-disciplinary service sees around 3000 patients per year. He has been highly commended for excellence in customer care and the paediatric allergy service has been nominated for a number of quality of care awards. The service offers innovative treatments including immunotherapy and specific oral tolerance induction to milk and egg. He is one of the authors of the Management of Cow's Milk Protein Allergy Guideline for BSACI and co-ordinates the Midlands Paediatric Allergy Group.
He is currently the Group Director for the Women and Child Health Group. He is trained as an APLS (Advanced Paediatric Life Support) course director, and trains doctors on the recognition and emergency management of children with life threatening conditions. In addition, he is the MBChB Paediatric Lead for the University of Birmingham and was previously the Training Programme Director for junior paediatric training in the West Midlands.
